Related Experiment Video
Updated: May 25, 2026
Quantification of Microglial Engulfment of Synaptic Material Using Flow Cytometry
Published on: May 31, 2024
Selective targeting of microglia by quantum dots
S Sakura Minami1, Binggui Sun, Ketul Popat
1Gladstone Institute of Neurological Disease, 1650 Owens St., San Francisco, CA 94158, USA.
Background:
Microglia, the resident immune cells of the brain, have been implicated in brain injury and various neurological disorders. However, their precise roles in different pathophysiological situations remain enigmatic and may range from detrimental to protective. Targeting the delivery of biologically active compounds to microglia could help elucidate these roles and facilitate the therapeutic modulation of microglial functions in neurological diseases.
Methods:
Here we employ primary cell cultures and stereotaxic injections into mouse brain to investigate the cell type specific localization of semiconductor quantum dots (QDs) in vitro and in vivo. Two potential receptors for QDs are identified using pharmacological inhibitors and neutralizing antibodies.
Results:
In mixed primary cortical cultures, QDs were selectively taken up by microglia; this uptake was decreased by inhibitors of clathrin-dependent endocytosis, implicating the endosomal pathway as the major route of entry for QDs into microglia. Furthermore, inhibiting mannose receptors and macrophage scavenger receptors blocked the uptake of QDs by microglia, indicating that QD uptake occurs through microglia-specific receptor endocytosis. When injected into the brain, QDs were taken up primarily by microglia and with high efficiency. In primary cortical cultures, QDs conjugated to the toxin saporin depleted microglia in mixed primary cortical cultures, protecting neurons in these cultures against amyloid beta-induced neurotoxicity.
Conclusions:
These findings demonstrate that QDs can be used to specifically label and modulate microglia in primary cortical cultures and in brain and may allow for the selective delivery of therapeutic agents to these cells.
Insights
Semiconductor quantum dots (QDs) are selectively absorbed by microglia, the brain's immune cells. This targeted uptake via specific receptors allows for potential therapeutic delivery to modulate microglial function in neurological diseases.
Area of Science:
- Neuroscience
- Immunology
- Nanotechnology
Background:
- Microglia are brain immune cells implicated in neurological disorders.
- Their exact roles in disease are unclear, potentially being harmful or protective.
- Targeting microglia could clarify their function and enable therapeutic interventions.
Purpose of the Study:
- Investigate the cell-specific localization of semiconductor quantum dots (QDs) in microglia.
- Identify receptors involved in QD uptake by microglia.
- Assess the potential of QDs for targeted delivery and therapeutic modulation of microglia.
Main Methods:
- Primary cell cultures and stereotaxic injections in mice were used.
- Pharmacological inhibitors and neutralizing antibodies identified QD receptors.
- QD uptake mechanisms, including endocytosis pathways, were examined.
Main Results:
- QDs were selectively taken up by microglia in vitro and in vivo.
- Uptake was mediated by mannose and macrophage scavenger receptors via endocytosis.
- QD-conjugated toxins depleted microglia, protecting neurons from amyloid beta toxicity.
Conclusions:
- QDs specifically label and can modulate microglia in brain cultures and in vivo.
- QDs offer a platform for targeted delivery of therapeutic agents to microglia.
- This approach may advance treatments for neurological diseases by targeting microglial function.
